192 related articles for article (PubMed ID: 24922009)
1. Sample features associated with success rates in population-based EGFR mutation testing.
Shiau CJ; Babwah JP; da Cunha Santos G; Sykes JR; Boerner SL; Geddie WR; Leighl NB; Wei C; Kamel-Reid S; Hwang DM; Tsao MS
J Thorac Oncol; 2014 Jul; 9(7):947-956. PubMed ID: 24922009
[TBL] [Abstract][Full Text] [Related]
2. [Thyroid transcription factor-1 level is associated with epidermal growth factor receptor mutation status in patients with advanced lung adenocarcinoma].
Niu Y; Wang H; Zhang G; Ma J; Wei B; Ma Z
Zhonghua Jie He He Hu Xi Za Zhi; 2014 Dec; 37(12):919-23. PubMed ID: 25609130
[TBL] [Abstract][Full Text] [Related]
3. Successful lung cancer EGFR sequencing from DNA extracted from TTF-1 immunohistochemistry slides: a new means to extend insufficient tissue.
Deftereos G; Sandoval A; Furtado LV; Bronner M; Matynia AP
Hum Pathol; 2020 Mar; 97():52-59. PubMed ID: 31978505
[TBL] [Abstract][Full Text] [Related]
4. The efficacy of EGFR gene mutation testing in various samples from non-small cell lung cancer patients: a multicenter retrospective study.
Krawczyk P; Ramlau R; Chorostowska-Wynimko J; Powrózek T; Lewandowska MA; Limon J; Wasąg B; Pankowski J; Kozielski J; Kalinka-Warzocha E; Szczęsna A; Wojas-Krawczyk K; Skroński M; Dziadziuszko R; Jaguś P; Antoszewska E; Szumiło J; Jarosz B; Woźniak A; Jóźwicki W; Dyszkiewicz W; Pasieka-Lis M; Kowalski DM; Krzakowski M; Jassem J; Milanowski J
J Cancer Res Clin Oncol; 2015 Jan; 141(1):61-8. PubMed ID: 25086987
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of EGFR mutations in newly diagnosed locally advanced or metastatic non-small cell lung cancer Spanish patients and its association with histological subtypes and clinical features: The Spanish REASON study.
Esteban E; Majem M; Martinez Aguillo M; Martinez Banaclocha N; Dómine M; Gómez Aldaravi L; Juan O; Cajal R; Gonzalez Arenas MC; Provencio M
Cancer Epidemiol; 2015 Jun; 39(3):291-7. PubMed ID: 25766256
[TBL] [Abstract][Full Text] [Related]
6. Cytology smears as diagnostic material for EGFR gene testing in non-small cell lung cancer.
Powrózek T; Krawczyk P; Pankowski J; Reszka K; Jakubiak M; Obrochta A; Wojas-Krawczyk K; Buczkowski J; Milanowski J
Tumori; 2015 Nov; 101(6):e151-3. PubMed ID: 26108238
[TBL] [Abstract][Full Text] [Related]
7. A comparison of ARMS and mutation specific IHC for common activating EGFR mutations analysis in small biopsy and cytology specimens of advanced non small cell lung cancer.
Wang X; Wang G; Hao Y; Xu Y; Zhang L
Int J Clin Exp Pathol; 2014; 7(7):4310-6. PubMed ID: 25120814
[TBL] [Abstract][Full Text] [Related]
8. Real-world data of EGFR mutation testing in Chinese non-small cell carcinoma: Low tumor cell number and tumor cellularity can be accepted.
Gu Y; Li Y; Zhao S; Jin M; Lu J; Jiang X
Pathol Res Pract; 2022 Aug; 236():153965. PubMed ID: 35700580
[TBL] [Abstract][Full Text] [Related]
9. [Analysis of the Relationship Between the Quality of Small Biopsy Specimens of
Non-small Cell Lung Cancer and the Mutation Rate of EGFR Gene].
Li Y; Gu Y; Jiang J
Zhongguo Fei Ai Za Zhi; 2021 May; 24(5):331-337. PubMed ID: 34034456
[TBL] [Abstract][Full Text] [Related]
10. Preanalytic parameters in epidermal growth factor receptor mutation testing for non-small cell lung carcinoma: A review of cytologic series.
da Cunha Santos G; Saieg MA
Cancer Cytopathol; 2015 Nov; 123(11):633-43. PubMed ID: 26288231
[TBL] [Abstract][Full Text] [Related]
11. EGFR mutation testing in lung cancer: a review of available methods and their use for analysis of tumour tissue and cytology samples.
Ellison G; Zhu G; Moulis A; Dearden S; Speake G; McCormack R
J Clin Pathol; 2013 Feb; 66(2):79-89. PubMed ID: 23172555
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of mutant p53, Ki-67, and TTF-1 and their correlation with EGFR mutation in patients with non-small cell lung cancer.
Zhu WY; Hu XF; Fang KX; Kong QQ; Cui R; Li HF; He JY; Zhang YK; Le HB
Histol Histopathol; 2019 Nov; 34(11):1269-1278. PubMed ID: 31062864
[TBL] [Abstract][Full Text] [Related]
13. Detection of epidermal growth factor receptor mutations in a few cancer cells from transbronchial cytologic specimens by reverse transcriptase-polymerase chain reaction.
Kanaji N; Bandoh S; Ishii T; Kushida Y; Haba R; Kohno K; Dobashi H; Ohnishi H; Matsunaga T
Mol Diagn Ther; 2011 Dec; 15(6):353-9. PubMed ID: 22117119
[TBL] [Abstract][Full Text] [Related]
14. [Detection of epidermal growth factor receptor mutations in non-small-cell lung carcinoma by direct sequencing and correlations with clinicopathological characteristics and sample types].
Sun MH; Yang F; Shen L; Zhang L; Chen Y; Cai X; Zhu XL; Zhou XY
Zhonghua Bing Li Xue Za Zhi; 2011 Oct; 40(10):655-9. PubMed ID: 22321541
[TBL] [Abstract][Full Text] [Related]
15. Establishing an EGFR mutation screening service for non-small cell lung cancer - sample quality criteria and candidate histological predictors.
Leary AF; Castro DG; Nicholson AG; Ashley S; Wotherspoon A; O'Brien ME; Popat S
Eur J Cancer; 2012 Jan; 48(1):61-7. PubMed ID: 22036089
[TBL] [Abstract][Full Text] [Related]
16. High feasibility of liquid-based cytological samples for detection of EGFR mutations in Chinese patients with NSCLC.
Wu CY; Hou LK; Ren SX; Su B; Chen G
Asian Pac J Cancer Prev; 2014; 15(18):7885-9. PubMed ID: 25292082
[TBL] [Abstract][Full Text] [Related]
17. Next-generation sequencing of lung cancer EGFR exons 18-21 allows effective molecular diagnosis of small routine samples (cytology and biopsy).
de Biase D; Visani M; Malapelle U; Simonato F; Cesari V; Bellevicine C; Pession A; Troncone G; Fassina A; Tallini G
PLoS One; 2013; 8(12):e83607. PubMed ID: 24376723
[TBL] [Abstract][Full Text] [Related]
18. Differences in epidermal growth factor receptor gene mutations and relationship with clinicopathological features in NSCLC between Uygur and Han ethnic groups.
Zhang Y; Wang Q; Han ZG; Shan L
Asian Pac J Cancer Prev; 2013; 14(5):2879-83. PubMed ID: 23803047
[TBL] [Abstract][Full Text] [Related]
19. Detection of EGFR gene mutations in non-small cell lung cancer: lessons from a single-institution routine analysis of 1,403 tumor samples.
Vallee A; Sagan C; Le Loupp AG; Bach K; Dejoie T; Denis MG
Int J Oncol; 2013 Oct; 43(4):1045-51. PubMed ID: 23934203
[TBL] [Abstract][Full Text] [Related]
20. Refining the diagnosis and EGFR status of non-small cell lung carcinoma in biopsy and cytologic material, using a panel of mucin staining, TTF-1, cytokeratin 5/6, and P63, and EGFR mutation analysis.
Nicholson AG; Gonzalez D; Shah P; Pynegar MJ; Deshmukh M; Rice A; Popat S
J Thorac Oncol; 2010 Apr; 5(4):436-41. PubMed ID: 20068475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
